Don’t forget the sun cream – it’s no surprise Starmer ‘badly needs holiday’ after unrelenting gloom
AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025
AbbVie’s third successful Parkinson’s trial sets the stage for an eventful 2025
AbbVie Inc. announced positive data from a third late-stage trial of a treatment for Parkinson’s disease on Monday and said it’s on track to seek approval for the drug from the Food and Drug Administration in 2025.
